Drawing for Serial No. 79157427

USPTO serial 79157427

Serial No. 79157427

Reviewed by CopyMark Law Group

Reg. 4779643Status 709
Filing date
Status date
Registration date
Jul 28, 2015
Examiner
LEASER, ANDREW C
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with Serial No. 79157427?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Maury M. Tepper, III

Maury M. Tepper, III Tepper & Eyster, PLLC3724 Benson DriveRaleigh, NC 27609UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-infective, antiviral preparations and antibioticsSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 26, 2022INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Oct 31, 2022INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Oct 31, 2022INPCINVALIDATION PROCESSED—
Oct 11, 2022INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Feb 11, 2022C71TCANCELLED SECTION 71—
Jul 28, 2020REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jan 4, 2016FINVFINAL DECISION TRANSACTION PROCESSED BY IB—
Dec 17, 2015FICSFINAL DISPOSITION NOTICE SENT TO IB—
Dec 17, 2015FIMPFINAL DISPOSITION PROCESSED—
Oct 28, 2015FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 28, 2015R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 12, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 12, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 8, 2015GPNXNOTIFICATION PROCESSED BY IB—
Apr 22, 2015OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 22, 2015OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Apr 22, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 3, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 27, 2015ALIEASSIGNED TO LIE—
Mar 9, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 9, 2015XAECEXAMINER'S AMENDMENT ENTERED—
Mar 9, 2015GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 9, 2015GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 9, 2015CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 6, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 6, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 6, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 20, 2015RFNTREFUSAL PROCESSED BY IB—
Feb 19, 2015ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 19, 2015REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 30, 2015RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jan 30, 2015RFRRREFUSAL PROCESSED BY MPU—
Jan 30, 2015RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jan 29, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 27, 2015DOCKASSIGNED TO EXAMINER—
Jan 9, 2015MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 5, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 30, 2014LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Dec 25, 2014REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance